Preclinical pharmacology of citalopram.
Popik
P
P
Institute of Pharmacology, Polish Academy of Sciences, Krakow. nfpopik@cyf-kr.edu.pl
D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D015283:Citalopram / Q000494:pharmacology*; D003866:Depressive Disorder / Q000503:physiopathology*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D018377:Neurotransmitter Agents / Q000502:physiology; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000502:physiology; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*
D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D018377:Neurotransmitter Agents; D017981:Receptors, Neurotransmitter; D011985:Receptors, Serotonin; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors